1. Home
  2. NRC vs STRO Comparison

NRC vs STRO Comparison

Compare NRC & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$20.04

Market Cap

440.1M

Sector

Health Care

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$29.19

Market Cap

491.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRC
STRO
Founded
1981
2003
Country
United States
United States
Employees
N/A
133
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.1M
491.0M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NRC
STRO
Price
$20.04
$29.19
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$31.33
AVG Volume (30 Days)
166.3K
268.6K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
3.86%
N/A
EPS Growth
4707.69
N/A
EPS
0.14
N/A
Revenue
$119,686,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$139.21
N/A
Revenue Growth
1.81
N/A
52 Week Low
$11.01
$0.67
52 Week High
$22.79
$43.85

Technical Indicators

Market Signals
Indicator
NRC
STRO
Relative Strength Index (RSI) 56.38 49.71
Support Level $18.03 $23.53
Resistance Level $21.33 $30.94
Average True Range (ATR) 1.17 2.84
MACD -0.06 0.53
Stochastic Oscillator 63.00 63.03

Price Performance

Historical Comparison
NRC
STRO

About NRC National Research Corporation (Delaware)

NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: